DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Morgan Stanley Maintains Equal-Weight on Core Laboratories, Lowers Price Target to $12

Morgan Stanley maintains Core Laboratories (NYSE:CLB) with a Equal-Weight and lowers the price target from $45 to $12.

Benzinga · 03/16/2020 14:54

Morgan Stanley maintains Core Laboratories (NYSE:CLB) with a Equal-Weight and lowers the price target from $45 to $12.